A recent study published in this journal suggests that the gut microbiome affects physical function in elderly patients with hypertension [1]. Analysis of the gut microbiome is currently a hot topic in research, because of its potential as a novel risk factor for several life-threatening conditions, including hypertension [1] and cardiovascular disease [2, 3]. For example, terminal restriction fragment length polymorphism (T-RFLP) analysis conducted by Emoto et al. revealed that the incidence of coronary artery disease (CAD) is linked to alterations of the gut microbiome [2]. Recently, we also demonstrated that the gut microbiome is independently and closely associated with the presence of dementia using T-RFLP analysis [4]. Although our analysis used a cross-sectional design and the causal relationship has yet to be clarified, comparisons focusing on similarities and differences in the gut microbiome between the CAD and dementia cohorts may be key to a better understanding of the role of the gut microbiome in these diseases.
Therefore, we carried out a preliminary comparison of the two cohorts with regard to the gut microbiome (Fig. 1). The CAD and dementia cohorts show certain differences in the proportions of male vs. female patients and in average patient age [2, 4]. Analysis of the intestinal microbiota of the CAD and dementia cohorts revealed that enterotype I (Bacteroides >30%) was most prevalent amongst the healthy volunteers (mean age: 59 years), followed by the CAD control group (62 years), patients with CAD (61 years), patients without dementia (76 years), and patients with dementia (77 years) (Fig. 1). In contrast, the prevalence of enterotype III (others) showed the reverse order. Thus, the prevalence of enterotype I appears to decrease with advancing age and may be inversely associated with the prevalence of vascular risk factors. In general, dementia patients are older and are more likely to have vascular risk factors, such as hypertension and diabetes mellitus [5]. Additionally, both age [6] and dietary parameters [7] are recognized as robust risk factors for the alteration of the gut microbiome.
This comparison between the two cohorts may be affected by the demographic differences in age and sex ratio and by the differing proportions of risk factors. Furthermore, it is difficult to draw solid conclusions given the varying incidences of enterotypes among the groups within the cohorts. However, analyzing the specific “other bacteria” indicated by enterotype III in more detail may help elucidate the mechanisms underlying the association between the gut microbiome and these life-threatening diseases. We speculate that microvascular inflammation associated with the gut microbiota may cause microvascular dysfunction [8], which could lead to both cardiovascular disease and dementia. Furthermore, the gene-environment-gut microbiome interaction may be associated with a particular disease state [9], and represents an exciting new target for potential disease therapies. Currently, comprehensive dementia research is an important topic in Japan [10]. Assessment of the gut microbiome as a potential risk factor for dementia may result in future healthcare advances. Therefore, further studies that take these factors into consideration are needed to clarify the clinical implications of gut microbiome analysis.
References
Yu Y, Mao G, Wang J, Zhu L, Lv X, Tong Q, et al. Gut dysbiosis is associated with the reduced exercise capacity of elderly patients with hypertension. Hypertens Res. 2018;41:1036–44.
Emoto T, Yamashita T, Sasaki N, Hirota Y, Hayashi T, So A, et al. Analysis of gut microbiota in coronary artery disease patients: a possible link between gut microbiota and coronary artery disease. J Atheroscler Thromb. 2016;23:908–21.
Yamashita T, Emoto T, Sasaki N, Hirata K. Gut microbiota and coronary artery disease. Int Heart J. 2016;57:663–71.
Saji N, Niida S, Murotani K, Hisada T, Sugimoto T, Kimura A, et al. Analysis of the relationship between the gut microbiome and dementia: a cross-sectional study conducted in Japan. Sci Rep. 2019;9. https://doi.org/10.1038/s41598-018-38218-7.
Livingston G, Sommerlad A, Orgeta V, Costafreda SG, Huntley J, Ames D, et al. Dementia prevention, intervention, and care. Lancet. 2017;390:2673–734.
Odamaki T, Kato K, Sugahara H, Hashikura N, Takahashi S, Xiao JZ, et al. Age-related changes in gut microbiota composition from newborn to centenarian: a cross-sectional study. BMC Microbiol. 2016;16:90.
Kushida M, Sugawara S, Asano M, Yamamoto K, Fukuda S, Tsuduki T. Effects of the 1975 Japanese diet on the gut microbiota in younger adults. J Nutr Biochem. 2018;64:121–7.
Junqueira CLC, Magalhães MEC, Brandão AA, Ferreira E, Cyrino FZGA, Maranhão PA, et al. Microcirculation and biomarkers in patients with resistant or mild-to-moderate hypertension: a cross-sectional study. Hypertens Res. 2018;41:515–23.
Chan Q, Loo RL, Ebbels TMD, Van Horn L, Daviglus ML, Stamler J, et al. Metabolic phenotyping for discovery of urinary biomarkers of diet, xenobiotics and blood pressure in the INTERMAP study: an overview. Hypertens Res. 2017;40:336–45.
Saji N, Sakurai T, Suzuki K, Mizusawa H, Toba K, ORANGE investigators. Orange’s challenge: developing wide-ranging dementia research in Japan. Lancet Neurol. 2016;15:661–2.
Acknowledgements
We thank Dr Tomoya Yamashita (Kobe University Graduate School of Medicine) and Dr Hiroko Kawasaki (Biological Resource Center, National Institute of Technology and Evaluation) for valuable discussions, and Tamsin Sheen, PhD, from Edanz Group (www.edanzediting.com/ac) for reviewing and editing a draft of this manuscript.
Funding
This study was supported by the research grants from the Research Funding of Longevity Sciences (26-20, 27-21, 28-15, 30-1), the National Center for Geriatrics and Gerontology, grants from the NARO Bio-oriented Technology Research Advancement Institution project (Advanced integration research for agriculture and interdisciplinary fields), and grants from the Toyoaki Scholarship Foundation.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
Research fund: NS, TT (NARO Bio-oriented Technology Research Advancement Institution Project); NS (National Centre for Geriatrics and Gerontology, BMS/Pfizer Japan, Toyoaki Scholarship Foundation, Japan Agency for Medical Research and Development (AMED)).
Additional information
Publisher’s note: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Saji, N., Hisada, T., Tsuduki, T. et al. Proportional changes in the gut microbiome: a risk factor for cardiovascular disease and dementia?. Hypertens Res 42, 1090–1091 (2019). https://doi.org/10.1038/s41440-019-0218-6
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41440-019-0218-6
This article is cited by
-
High intake of ultra-processed food is associated with dementia in adults: a systematic review and meta-analysis of observational studies
Journal of Neurology (2024)
-
Relationship between dementia and gut microbiome-associated metabolites: a cross-sectional study in Japan
Scientific Reports (2020)
-
The relationship between the gut microbiome and mild cognitive impairment in patients without dementia: a cross-sectional study conducted in Japan
Scientific Reports (2019)